Related Experiment Video
Updated: Jan 21, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Sergei S Zainutdinov1, Galina V Kochneva1, Sergei V Netesov2
1State Research Center of Virology and Biotechnology "Vector" , Koltsovo 630559, Russia.
Abstract:
Viruses have some characteristics in common with cell-based life. They can evolve and adapt to environmental conditions. Directed evolution can be used by researchers to produce viral strains with desirable phenotypes. Through bioselection, improved strains of oncolytic viruses can be obtained that have better safety profiles, increased specificity for malignant cells, and more efficient spread among tumor cells. It is also possible to select strains capable of killing a broader spectrum of cancer cell variants, so as to achieve a higher frequency of therapeutic responses. This review describes and analyses virus adaptation studies performed with members of four RNA virus families that are used for viral oncolysis: reoviruses, paramyxoviruses, enteroviruses, and rhabdoviruses.
Insights
Researchers use directed evolution to enhance oncolytic viruses for cancer therapy. This involves adapting viral strains to improve safety, tumor cell targeting, and efficacy against diverse cancer types.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Viruses share life-like characteristics, including evolution and adaptation.
- Directed evolution offers a method to engineer viral strains with specific traits.
- Oncolytic viruses are engineered to target and destroy cancer cells.
Purpose of the Study:
- To review and analyze virus adaptation studies for oncolytic virotherapy.
- To explore the use of directed evolution in improving oncolytic virus phenotypes.
- To discuss the selection of viral strains with enhanced anti-cancer properties.
Main Methods:
- Bioselection techniques applied to viral strains.
- Directed evolution strategies for phenotype modification.
- Analysis of adaptation studies across four RNA virus families.
Main Results:
- Improved oncolytic virus safety profiles achieved through adaptation.
- Enhanced specificity and spread of engineered viruses within tumor cells.
- Selection of strains with broader cancer cell targeting capabilities.
Conclusions:
- Virus adaptation is a viable strategy for developing effective oncolytic virotherapies.
- Directed evolution can yield oncolytic viruses with superior therapeutic potential.
- Further research into virus adaptation holds promise for advancing cancer treatment.
Related Concept Videos
Desirable Characteristics in Others
The Evidence for Evolution
Viruses with RNA Genomes
Convergent Evolution
What are Viruses?
What is Natural Selection?

